SMARCA2 and hepatocellular carcinoma: An association between other BRM genetic variants and hepatocellular carcinoma (HCC) risk was also reported in two separate case-control studies in Chinese patients (though those specific genetic variants appeared to be restricted mainly to patients of East Asian descent).